Literature DB >> 11254442

Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts.

P A Leegwater1, B Q Yuan, J van der Steen, J Mulders, A A Könst, P K Boor, V Mejaski-Bosnjak, S M van der Maarel, R R Frants, C B Oudejans, R B Schutgens, J C Pronk, M S van der Knaap.   

Abstract

Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is an autosomal recessive disorder characterized by macrocephaly, deterioration of motor functions with ataxia, and spasticity, eventuating in mental decline. The brain appears swollen on magnetic resonance imaging, with diffuse white-matter abnormalities and the invariable presence of subcortical cysts. MLC was recently localized on chromosome 22q(tel). We have narrowed down the critical region by linkage analysis of 11 informative families with MLC to a region of approximately 250 kb, containing four known genes. One family with two patients who were siblings did not display linkage between the MLC phenotype and any of the analyzed microsatellite markers on chromosome 22q(tel), suggesting genetic heterogeneity and the existence of at least a second MLC locus. The maximum two-point LOD score for the 11 families was 6.6 at recombination fraction .02. Twelve different mutations in seven informative and six uninformative families were found in one of the candidate genes, KIAA0027, which we renamed "MLC1." The gene encodes a putative membrane protein with eight predicted transmembrane domains. The patients of one family were compound heterozygotes for mutations that both introduced stop codons. The mutations further included frameshifts, splice-acceptor mutations, a putative splice-donor mutation, and amino acid substitutions of residues in predicted transmembrane domains. These data provide strong evidence that mutations of MLC1 cause the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254442      PMCID: PMC1275636          DOI: 10.1086/319519

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  The DNA sequence of human chromosome 22.

Authors:  I Dunham; N Shimizu; B A Roe; S Chissoe; A R Hunt; J E Collins; R Bruskiewich; D M Beare; M Clamp; L J Smink; R Ainscough; J P Almeida; A Babbage; C Bagguley; J Bailey; K Barlow; K N Bates; O Beasley; C P Bird; S Blakey; A M Bridgeman; D Buck; J Burgess; W D Burrill; K P O'Brien
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

Authors:  M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

3.  Megalencephalic leukodystrophy in an Asian Indian ethnic group.

Authors:  B S Singhal; R D Gursahani; V P Udani; A A Biniwale
Journal:  Pediatr Neurol       Date:  1996-05       Impact factor: 3.372

4.  Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1.

Authors:  N Nomura; N Miyajima; T Sazuka; A Tanaka; Y Kawarabayasi; S Sato; T Nagase; N Seki; K Ishikawa; S Tabata
Journal:  DNA Res       Date:  1994       Impact factor: 4.458

5.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

6.  The gene for leukoencephalopathy with vanishing white matter is located on chromosome 3q27.

Authors:  P A Leegwater; A A Könst; B Kuyt; L A Sandkuijl; S Naidu; C B Oudejans; R B Schutgens; J C Pronk; M S van der Knaap
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

7.  Vacuoliting megalencephalic leukoencephalopathy with subcortical cysts, mapped to chromosome 22qtel.

Authors:  M Topçu; C Gartioux; F Ribierre; C Yalçinkaya; E Tokus; N Oztekin; J S Beckmann; M Ozguc; E Seboun
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

8.  High frequency of large intragenic deletions in the Fanconi anemia group A gene.

Authors:  N V Morgan; A J Tipping; H Joenje; C G Mathew
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

9.  Megalencephaly and leukodystrophy with mild clinical course: a report on 12 new cases.

Authors:  M Topcu; I Saatci; M A Topcuoglu; G Kose; B Kunak
Journal:  Brain Dev       Date:  1998-04       Impact factor: 1.961

10.  Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene.

Authors:  M Wijker; N V Morgan; S Herterich; C G van Berkel; A J Tipping; H J Gross; J J Gille; G Pals; M Savino; C Altay; S Mohan; I Dokal; J Cavenagh; J Marsh; M van Weel; J J Ortega; D Schuler; E Samochatova; M Karwacki; A N Bekassy; M Abecasis; W Ebell; M L Kwee; T de Ravel
Journal:  Eur J Hum Genet       Date:  1999-01       Impact factor: 4.246

View more
  68 in total

1.  The beta1 subunit of the Na,K-ATPase pump interacts with megalencephalic leucoencephalopathy with subcortical cysts protein 1 (MLC1) in brain astrocytes: new insights into MLC pathogenesis.

Authors:  Maria S Brignone; Angela Lanciotti; Pompeo Macioce; Gianfranco Macchia; Matteo Gaetani; Francesca Aloisi; Tamara C Petrucci; Elena Ambrosini
Journal:  Hum Mol Genet       Date:  2010-10-06       Impact factor: 6.150

Review 2.  Brain connexins in demyelinating diseases: therapeutic potential of glial targets.

Authors:  Maria Luisa Cotrina; Maiken Nedergaard
Journal:  Brain Res       Date:  2012-07-10       Impact factor: 3.252

3.  Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31.

Authors:  Geneviève Bernard; Isabelle Thiffault; Martine Tetreault; Maria Lisa Putorti; Isabelle Bouchard; Michel Sylvain; Serge Melançon; Rachel Laframboise; Pierre Langevin; Jean-Pierre Bouchard; Michel Vanasse; Adeline Vanderver; Guillaume Sébire; Bernard Brais
Journal:  Neurogenetics       Date:  2010-07-17       Impact factor: 2.660

4.  Novel infantile-onset leukoencephalopathy with high lactate level and slow improvement.

Authors:  Marjan E Steenweg; Adeline Vanderver; Berten Ceulemans; Prab Prabhakar; Luc Régal; Aviva Fattal-Valevski; Lawrence Richer; Barbara Goeggel Simonetti; Frederik Barkhof; Richard J T Rodenburg; Petra J W Pouwels; Marjo S van der Knaap
Journal:  Arch Neurol       Date:  2012-06

5.  Brain-specific deletion of extracellular signal-regulated kinase 2 mitogen-activated protein kinase leads to aberrant cortical collagen deposition.

Authors:  Daniel S Heffron; Gary E Landreth; Ivy S Samuels; James W Mandell
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

6.  Stratification of astrocytes in healthy and diseased brain.

Authors:  Alexei Verkhratsky; Robert Zorec; Vladimir Parpura
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

Review 7.  Systematic approaches to central nervous system myelin.

Authors:  Patricia de Monasterio-Schrader; Olaf Jahn; Stefan Tenzer; Sven P Wichert; Julia Patzig; Hauke B Werner
Journal:  Cell Mol Life Sci       Date:  2012-03-23       Impact factor: 9.261

8.  Invited article: an MRI-based approach to the diagnosis of white matter disorders.

Authors:  Raphael Schiffmann; Marjo S van der Knaap
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

Review 9.  Tools for diagnosis of leukodystrophies and other disorders presenting with white matter disease.

Authors:  Adeline Vanderver
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

10.  Leukoencephalopathy-causing CLCN2 mutations are associated with impaired Cl- channel function and trafficking.

Authors:  Héctor Gaitán-Peñas; Pirjo M Apaja; Tanit Arnedo; Aida Castellanos; Xabier Elorza-Vidal; David Soto; Xavier Gasull; Gergely L Lukacs; Raúl Estévez
Journal:  J Physiol       Date:  2017-10-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.